Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.23%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.10%) $2 349.60
Silver
(-0.07%) $27.52
Platinum
(0.25%) $924.40
USD/EUR
(0.36%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.14%) $0.800
USD/RUB
(-0.07%) $92.11

Actualizaciones en tiempo real para Roquefort Therapeutics [ROQ.L]

Bolsa: LSE Sector: Healthcare Industria: Biotechnology
Última actualización26 abr 2024 @ 09:29
25% discount on Stockinvest.us - Use code: Podcast

0.00% £ 4.55

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 09:29):

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer...

Stats
Volumen de hoy 421 949
Volumen promedio 378 067
Capitalización de mercado 5.88M
EPS £0 ( 2023-09-27 )
Próxima fecha de ganancias ( £0 ) 2024-06-03
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -2.27
ATR14 £0 (0.00%)

Roquefort Therapeutics Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Roquefort Therapeutics Finanzas

Annual 2023
Ingresos: £200 000
Beneficio Bruto: £196 110 (98.06 %)
EPS: £-0.0135
FY 2023
Ingresos: £200 000
Beneficio Bruto: £196 110 (98.06 %)
EPS: £-0.0135
FY 2022
Ingresos: £0
Beneficio Bruto: £0 (0.00 %)
EPS: £-0.0156

Financial Reports:

No articles found.

Roquefort Therapeutics

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico